• linkedin
  • Increase Font
  • Sharebar

    Guidelines diverge around atopic dermatitis management


    A reflection of specialties

    Differences in treatment recommendations also reflect the unique expertise of the two specialties. The AAD guideline say injection immunotherapy cannot be routinely recommended whereas according to the JTF, this modality can be considered in selected patients with aeroallergen sensitivity.

    RECOMMENDED: Rheumatoid arthritis drug may benefit atopic dermatitis patients

    In the allergy guidelines a systemic antihistamine is identified as potentially beneficial for relieving itch associated with AD in some patients, whereas the AAD guideline concludes there is insufficient evidence to recommend such use.
    “The available evidence is pretty convincing that an antihistamine is not helpful for relieving itch in AD, and that is supported by my anecdotal experience discontinuing anthistamines in patients that were using them on their own or based on their allergist’s recommendation,” Dr. Lio says.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow